Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.

Antiphospholipid antibodies are strongly associated with arterial and venous thrombosis and with fetal loss. Recently an experimental model for antiphospholipid syndrome (APLS) was established in our laboratory. In this model, mice are immunized passively or actively with anticardiolipin antibodies...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Fishman, P, Falach-Vaknine, E, Zigelman, R, Bakimer, R, Sredni, B, Djaldetti, M, Shoenfeld, Y
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC288166/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8473523/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116396
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!